Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection.

Sreenarasimhaiah, Jayaprakash

Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection. [electronic resource] - Human immunology May 2003 - 497-504 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

0198-8859

10.1016/s0198-8859(03)00041-7 doi


Antiviral Agents--therapeutic use
CD4-Positive T-Lymphocytes--drug effects
CD8-Positive T-Lymphocytes--drug effects
Drug Therapy, Combination
Enzyme-Linked Immunosorbent Assay
Epitopes
Hepacivirus--drug effects
Hepatitis C, Chronic--drug therapy
Humans
Interferon-alpha--therapeutic use
Male
Middle Aged
Prospective Studies
Ribavirin--therapeutic use
Time Factors
Treatment Outcome
Viral Load